ERNA
Ernexa Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.31
−4.86%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-383.0%
Return on equity
-194.1%
Return on assets
-330.7%
Return on invested capital
0.00x
Asset turnover
-$8.8M
Cash from operations
$3.08
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026